Oligonucleotide synthesis is the process of building short sequences of nucleotides, the building blocks of DNA and RNA, using chemical techniques. Oligonucleotides are typically short, single-stranded pieces of nucleic acid that can be used for a variety of purposes, including as probes for detecting specific nucleic acid sequences, primers for PCR amplification, and as therapeutic agents in gene therapy.
Request Report Sample: https://www.alliedmarketresearch.com/request-sample/8721
- CAGR: 17.1%
• Current Market Size: USD 197.5 Million
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2021- 2031
• Base Year: 2021
Oligonucleotide Synthesis Market
The oligonucleotide synthesis market refers to the industry that produces and sells synthetic oligonucleotides, which are short strands of nucleic acid that are used in various applications, such as research, diagnostics, and therapeutics. The market has seen steady growth in recent years due to the increasing demand for oligonucleotides in molecular biology and biotechnology.
One major driver of the oligonucleotide synthesis market is the growing demand for oligonucleotides in research and diagnostic applications. Oligonucleotides are used as probes for detecting specific nucleic acid sequences, as primers for PCR amplification, and as tools for studying gene expression and regulation.
Procure Complete Report (243 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/2df86ceb32d9250a1d7ea0c2e1db6897
COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The COVID-19 pandemic has helped the oligonucleotide synthesis industry grow significantly, as the demand for synthesized oligonucleotide products has increased, as it helps with the treatment of corona. oligo products are required for developing test kits, treatments, and vaccines that target the infection caused by the novel Coronavirus.
Moreover, with the increasing cases of coronavirus disease (COVID-19) and the urgency for a potential treatment, new generations of oligonucleotide drugs, including mRNA and DNA vaccines, are currently under development. This supports the oligonucleotide synthesis market to gain traction during the forecast period.
The market for oligonucleotide synthesis is highly competitive, with a number of major players, including
Thermo Fisher Scientific,
Integrated DNA Technologies,
and Eurofins Scientific.
For purchase inquiries: https://www.alliedmarketresearch.com/purchase-enquiry/8721